CA2771564C - Utilisations de formulations d'analogues de l'hormone thyroidienne et de formes nanoparticulaires de celles-ci pour augmenter la chemosensibilite et la radiosensibilite dans les cellules tumorales ou cancereuses - Google Patents
Utilisations de formulations d'analogues de l'hormone thyroidienne et de formes nanoparticulaires de celles-ci pour augmenter la chemosensibilite et la radiosensibilite dans les cellules tumorales ou cancereuses Download PDFInfo
- Publication number
- CA2771564C CA2771564C CA2771564A CA2771564A CA2771564C CA 2771564 C CA2771564 C CA 2771564C CA 2771564 A CA2771564 A CA 2771564A CA 2771564 A CA2771564 A CA 2771564A CA 2771564 C CA2771564 C CA 2771564C
- Authority
- CA
- Canada
- Prior art keywords
- tetrac
- thyroid hormone
- cells
- cancer
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Linvention concerne des méthodes permettant daugmenter la chimiosensibilité des cellules tumorales ou cancéreuses normales ou chimiorésistantes à laide danalogues de lhormone thyroïdienne ou de formes nanoparticulaires ou polymériques de celles-ci. Linvention concerne aussi des méthodes permettant daugmenter la radiosensibilité des cellules tumorales ou cancéreuses normales ou radiorésistantes à laide danalogues de lhormone thyroïdienne ou de formes nanoparticulaires ou polymériques de celles-ci.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/345,194 US8802240B2 (en) | 2011-01-06 | 2012-01-06 | Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells |
| US13/345,194 | 2012-01-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2771564A1 CA2771564A1 (fr) | 2013-07-06 |
| CA2771564C true CA2771564C (fr) | 2018-08-28 |
Family
ID=48743655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2771564A Active CA2771564C (fr) | 2012-01-06 | 2012-03-16 | Utilisations de formulations d'analogues de l'hormone thyroidienne et de formes nanoparticulaires de celles-ci pour augmenter la chemosensibilite et la radiosensibilite dans les cellules tumorales ou cancereuses |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2771564C (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12043590B2 (en) | 2018-10-17 | 2024-07-23 | Sandoz Ag | Co-crystals comprising levothyroxine and a dicarboxylic acid |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112899229B (zh) * | 2019-12-04 | 2024-02-27 | 深圳先进技术研究院 | 用于增加癌细胞药物敏感性的生物材料及其应用和细胞培养器皿 |
| CN111944746B (zh) * | 2020-08-04 | 2022-05-06 | 山东中医药大学 | 一种热刺激诱导细胞凋亡的方法 |
| AU2022206798B2 (en) * | 2022-07-21 | 2025-07-03 | Taipei Medical University | Self-assembled nanoparticle and use thereof for anti- angiogenesis |
| CN115759785B (zh) * | 2022-12-06 | 2025-03-18 | 常州通用自来水有限公司 | 一种基于k-means均值聚类的DMA小区漏损评价方法 |
-
2012
- 2012-03-16 CA CA2771564A patent/CA2771564C/fr active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12043590B2 (en) | 2018-10-17 | 2024-07-23 | Sandoz Ag | Co-crystals comprising levothyroxine and a dicarboxylic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2771564A1 (fr) | 2013-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9839614B2 (en) | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof | |
| US8802240B2 (en) | Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells | |
| CA2673133C (fr) | Formulations de nanoparticules et de polymeres pour les analogues, les antagonistes et les formulations de l'hormone thyroide et leurs utilisations | |
| CA2648243C (fr) | Nanoparticule et formes polymeres d'analogues et d'antagonistes de l'hormone thyroidienne et leurs formulations | |
| US8668926B1 (en) | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof | |
| US20090022806A1 (en) | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof | |
| Yu et al. | Inhibiting metastasis and preventing tumor relapse by triggering host immunity with tumor-targeted photodynamic therapy using photosensitizer-loaded functional nanographenes | |
| CA2771564C (fr) | Utilisations de formulations d'analogues de l'hormone thyroidienne et de formes nanoparticulaires de celles-ci pour augmenter la chemosensibilite et la radiosensibilite dans les cellules tumorales ou cancereuses | |
| AU2016321431A1 (en) | Bioorthogonal compositions | |
| CN101102758A (zh) | 促进血管新生的甲状腺激素类似物 | |
| CN113365613A (zh) | 透明质酸和表没食子儿茶素-3-o-没食子酸酯的缀合物和纳米颗粒及其用途 | |
| EP2662079A1 (fr) | Utilisations de formulations d'antagonistes d'hormone thyroïdienne et leurs formes nanoparticulaires associées pour augmenter la chimio-sensibilité et radio-sensibilité dans les cellules cancéreuses ou tumorales | |
| Chen et al. | Response of pH-sensitive doxorubicin nanoparticles on complex tumor microenvironments by tailoring multiple physicochemical properties | |
| Yu et al. | A Supramolecular nitric oxide nanodelivery system for prevention of tumor metastasis by inhibiting platelet activation and aggregation | |
| AU2007309727A1 (en) | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof | |
| JP2021130674A (ja) | アミノチオール及びその類似体の改善された保護及び送達のための方法 | |
| Zhang et al. | Multifunctional dendritic Au@ SPP@ DOX nanoparticles integrating chemotherapy and low-dose radiotherapy for enhanced anticancer activity | |
| US20250049936A1 (en) | Bioorthogonal compositions | |
| ES2535134T3 (es) | Análogos de hormonas tiroideas para inhibir la angiogénesis | |
| CN114903872A (zh) | 共递雷公藤红素和Bcl-2-功能转换肽的树状大分子自组装体及制备方法与应用 | |
| CN121668331A (zh) | 一种双靶向肝细胞癌纳米药物的制备方法及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160128 |
|
| H11 | Ip right ceased following rejected request for revival |
Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED Effective date: 20240918 |